Activating pyruvate kinase R

The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Gustafson, Gary, Lin, Jian, Mitchell, Lorna, Richard, David, Lancia, Jr., David R, Ericsson, Anna, Green, Neal, Shelekhin, Tatiana, Zheng, Xiaozhang
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Gustafson, Gary
Lin, Jian
Mitchell, Lorna
Richard, David
Lancia, Jr., David R
Ericsson, Anna
Green, Neal
Shelekhin, Tatiana
Zheng, Xiaozhang
description The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US12122778B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US12122778B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US12122778B23</originalsourceid><addsrcrecordid>eNrjZJBxTC7JLEssycxLVyioLCoFMlMVsjPzEotTFYJ4GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8aLChkaGRkbm5hZORMTFqAKiiI-o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Activating pyruvate kinase R</title><source>esp@cenet</source><creator>Gustafson, Gary ; Lin, Jian ; Mitchell, Lorna ; Richard, David ; Lancia, Jr., David R ; Ericsson, Anna ; Green, Neal ; Shelekhin, Tatiana ; Zheng, Xiaozhang</creator><creatorcontrib>Gustafson, Gary ; Lin, Jian ; Mitchell, Lorna ; Richard, David ; Lancia, Jr., David R ; Ericsson, Anna ; Green, Neal ; Shelekhin, Tatiana ; Zheng, Xiaozhang</creatorcontrib><description>The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241022&amp;DB=EPODOC&amp;CC=US&amp;NR=12122778B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20241022&amp;DB=EPODOC&amp;CC=US&amp;NR=12122778B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gustafson, Gary</creatorcontrib><creatorcontrib>Lin, Jian</creatorcontrib><creatorcontrib>Mitchell, Lorna</creatorcontrib><creatorcontrib>Richard, David</creatorcontrib><creatorcontrib>Lancia, Jr., David R</creatorcontrib><creatorcontrib>Ericsson, Anna</creatorcontrib><creatorcontrib>Green, Neal</creatorcontrib><creatorcontrib>Shelekhin, Tatiana</creatorcontrib><creatorcontrib>Zheng, Xiaozhang</creatorcontrib><title>Activating pyruvate kinase R</title><description>The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBxTC7JLEssycxLVyioLCoFMlMVsjPzEotTFYJ4GFjTEnOKU3mhNDeDoptriLOHbmpBfnxqcUFicmpeakl8aLChkaGRkbm5hZORMTFqAKiiI-o</recordid><startdate>20241022</startdate><enddate>20241022</enddate><creator>Gustafson, Gary</creator><creator>Lin, Jian</creator><creator>Mitchell, Lorna</creator><creator>Richard, David</creator><creator>Lancia, Jr., David R</creator><creator>Ericsson, Anna</creator><creator>Green, Neal</creator><creator>Shelekhin, Tatiana</creator><creator>Zheng, Xiaozhang</creator><scope>EVB</scope></search><sort><creationdate>20241022</creationdate><title>Activating pyruvate kinase R</title><author>Gustafson, Gary ; Lin, Jian ; Mitchell, Lorna ; Richard, David ; Lancia, Jr., David R ; Ericsson, Anna ; Green, Neal ; Shelekhin, Tatiana ; Zheng, Xiaozhang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US12122778B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Gustafson, Gary</creatorcontrib><creatorcontrib>Lin, Jian</creatorcontrib><creatorcontrib>Mitchell, Lorna</creatorcontrib><creatorcontrib>Richard, David</creatorcontrib><creatorcontrib>Lancia, Jr., David R</creatorcontrib><creatorcontrib>Ericsson, Anna</creatorcontrib><creatorcontrib>Green, Neal</creatorcontrib><creatorcontrib>Shelekhin, Tatiana</creatorcontrib><creatorcontrib>Zheng, Xiaozhang</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gustafson, Gary</au><au>Lin, Jian</au><au>Mitchell, Lorna</au><au>Richard, David</au><au>Lancia, Jr., David R</au><au>Ericsson, Anna</au><au>Green, Neal</au><au>Shelekhin, Tatiana</au><au>Zheng, Xiaozhang</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Activating pyruvate kinase R</title><date>2024-10-22</date><risdate>2024</risdate><abstract>The disclosure provides novel chemical compounds useful as activators of PKR. PKR activating compounds are useful in the treatment of disease and disorders associated with modulation of PKR and/or PKM2, such as pyruvate kinase deficiency (PKD).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US12122778B2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Activating pyruvate kinase R
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T21%3A06%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gustafson,%20Gary&rft.date=2024-10-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS12122778B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true